Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing...

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Wogonin, a plant monoflavonoid, exhibits anti-cancer properties by inhibiting cell growth and inducing apoptosis in various tumor types.
• Understanding the precise mechanisms of wogonin's action is crucial for its therapeutic development.

Purpose of the Study:

• To investigate the apoptosis-inducing activity of wogonin in A549 lung cancer cells.
• To elucidate the underlying molecular mechanisms, including effects on key signaling pathways and protein degradation.

Main Methods:

• Cell viability assays were performed to assess wogonin's effect on A549 cells.
• Western blot analysis was used to examine changes in apoptotic proteins (XIAP, Mcl-1, cleaved-PARP, AIF, cytochrome C) and signaling pathway components (c-Myc, Skp2, HDAC1, HDAC2, Fbw7α, GSK3β, Thr58-Myc).
• Quantitative PCR was employed to analyze c-Myc mRNA levels.

Main Results:

• Wogonin significantly inhibited A549 cell viability and induced apoptosis, evidenced by altered expression of apoptotic proteins and release of AIF and cytochrome C.
• Wogonin decreased the activity of c-Myc/Skp2 and HDAC1/HDAC2 pathways, crucial for tumor progression.
• While c-Myc mRNA levels increased, its protein levels decreased, suggesting post-transcriptional regulation. Wogonin's effect on c-Myc degradation appeared independent of Fbw7α.

Conclusions:

• Wogonin demonstrates potent anti-cancer effects in A549 cells through multiple mechanisms, including the degradation of c-Myc, SKP2, HDAC1, and HDAC2.
• Its ability to induce apoptosis independently of Fbw7α suggests potential utility in treating Fbw7 deficiency-related drug-resistant cancers.
• Further research is warranted to explore the specific pathways involved in c-Myc and Fbw7α regulation and the role of GSK3β in c-Myc phosphorylation.